Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wall DA et al. – All children were engrafted with documented donor chimerism. No late rejections or graft failures occurred. Four patients had veno–occlusive disease, three of which resolved within 2 weeks of onset. Two children died from transplant–related causes unrelated to Bu. IVBu is a safe and effective and offers the benefit of predictable and consistent systemic exposure.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address